Shots:
AI is redefining visibility in pharma as it becomes the primary gateway to information, requiring companies to shift from content publishing to engineering discoverability with machine-readable, well-cited, and rapidly updated data to be included in AI-generated summaries
Integrated, structured evidence is now critical for success in AI-driven environments, demanding modular, metadata-rich, and consistent data…
Shots:
In this episode of the CXO Talks podcast, PharmaShots spoke with Tim O’Connell, CEO of Emtelligent, a next-generation medical AI company
Tim highlights Emtelligent’s inspiring journey to becoming a leader in a clinical-grade NLP company focused on transforming unstructured data to actionable insights at an enterprise scale
Emtelligent leverages the power of medical records…

